Avita Medical | 1811094D - 貿易債務者

株価
1.17
毎日の変更
-0.08 -6.40%
毎月
-2.09%
毎年
-61.26%
Q1 予測
1.23


金融部門
株価
AUD
資産
AUD 56.39M
現金と同等
AUD 10.24M
売上原価
AUD 3.3M
流動資産
AUD 35.49M
流動負債
AUD 62.68M
負債
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
従業員
AUD 87
株当たりのEPS利益
AUD -0.38
自己資本および準備金
AUD -16.65M
売上総利益
AUD 14.31M
債務の支払利息
AUD 1.25M
借入資本
AUD 42.25M
時価総額
AUD 154.06M
当期純利益
AUD -11.62M
営業経費
AUD 28.02M
営業利益
AUD -10.41M
税引前利益
AUD -11.64M
販売収入
AUD 17.62M
販売および管理費
AUD 19.03M
株式
AUD 6.93M
貿易債権者
AUD 8.96M
貿易債務者
AUD 9.11M


貿易債務者 変化する 日付
Accuray USD 91.79M 7.07M 2024-09
Celltrion KRW 1.51T 128.69B 2025-09
Clinuvel Pharmaceuticals AUD 26.24M 13.16M 2024-06
Cochlear AUD 568.4M 17.5M 2025-12
CSL USD 4.32B 1.35B 2025-12
Cspc Pharmaceutical CNY 8.85B 769.12M 2025-06
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Kangmei Pharma CNY 3.15B 295.48M 2025-09
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Mayne Pharma AUD 193.22M 5.64M 2024-06
Medical Developments International AUD 7.48M 174K 2025-12
Nanosonics AUD 46.45M 8.2M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organigram Holdings CAD 64.86M 7.31M 2025-09
Ovoca Bio EUR 447K 113K 2022-06
Pacific Edge NZD 3.75M 1.22M 2025-12
Paradigm Biopharmaceuticals AUD 6.37M 4.2K 2025-06
Pharma Mar EUR 60.6M 18.83M 2025-12
Polynovo AUD 20.72M 5.22M 2024-06
PYC Therapeutics AUD 32.59M 8.52M 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
Ramsay Health Care AUD 2.48B 22.3M 2025-12
ResMed USD 1.05B 88.62M 2025-12
Sartorius EUR 344.7M 48.5M 2025-09
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Telix Pharmaceuticals AUD 135.24M 5.72M 2025-12
Tilray USD 109.07M 2M 2025-09
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.12B 222.78M 2025-09